The Comparative Oncology Trials Consortium: Using Spontaneously Occurring Cancers in Dogs to Inform the Cancer Drug Development Pathway

Chand Khanna and colleagues describe the work of the Comparative Oncology Trials Consortium (COTC), which provides infrastructure and resources to integrate naturally occurring dog cancer models into the development of new human cancer drugs, devices, and imaging techniques.

Detalles Bibliográficos
Autores principales: Gordon, Ira, Paoloni, Melissa, Mazcko, Christina, Khanna, Chand
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Health in Action
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753665/
https://www.ncbi.nlm.nih.gov/pubmed/19823573
http://dx.doi.org/10.1371/journal.pmed.1000161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753665/
https://www.ncbi.nlm.nih.gov/pubmed/19823573
http://dx.doi.org/10.1371/journal.pmed.1000161

Ejemplares similares